RAY1225
The Safety, Tolerability and Pharmacokinetic Study of RAY1225
Guangdong Raynovent Biotech Co · Phase 1 · Completed · Enrollment 68
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
RAY1225
Guangdong Raynovent Biotech Co · Phase 1 · Completed · Enrollment 68
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.